Efficacy of the Low Dose Apatinib plus Chemotherapy on Advanced Gastric Carcinoma

Table 2

Comparison of the therapeutic effects of different programs on patients ( (%)).

Groups		Therapeutic effects				Control rate
		CR	PR	SD	PD
Control group	25	0 (0%)	3 (12%)	8 (32%)	14 (56%)	(12) 44%
Observation group	25	0 (0%)	9 (36%)	11 (44%)	5 (20%)	(20) 80%
						6.88
						<0.01

Note: CR: complete response; PR: partial response; SD: stable disease; PD: progressive disease.